Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees
- PMID: 17604304
- PMCID: PMC2083582
- DOI: 10.1136/adc.2006.114801
Selective ambulatory management of Plasmodium falciparum malaria in paediatric refugees
Abstract
Background: Plasmodium falciparum (Pf) malaria is a leading cause of childhood mortality and morbidity. In developed countries, it is widely recommended that even patients with uncomplicated Pf malaria are hospitalised for at least 24 h, whereas ambulatory treatment is usual for uncomplicated infections in developing countries. This observational study assessed the safety of selective admission of paediatric refugees with Pf malaria in Australia.
Methods: Data were collected on African humanitarian refugee children (<16 years of age) presenting with malaria between February 2005 and April 2006. Children were treated as outpatients if they fulfilled specific criteria devised to maximise the safety of outpatient management of this potentially life-threatening condition.
Results: Ninety paediatric refugees were infected with P falciparum, of whom 56 were treated as outpatients. Of the 34 children admitted to hospital, four had parasite loads > or =4%. Most children were treated with oral atovaquone-proguanil. Eighty eight patients attended follow-up; all were compliant and none reported side-effects. One infant failed treatment and was subsequently readmitted; he did not meet criteria for severe malaria on either occasion and had been initially treated as an inpatient.
Conclusions: Using this protocol, outpatient management of refugee children with Pf malaria appears safe, with minimal complication and treatment failure rates. This approach has rationalised management of paediatric malaria in this carefully selected population and substantially reduced utilisation of hospital resources.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Efficacy and safety of atovaquone-proguanil compared with mefloquine in the treatment of nonimmune patients with uncomplicated P. falciparum malaria in Japan.J Infect Chemother. 2006 Oct;12(5):277-82. doi: 10.1007/s10156-006-0465-8. Epub 2006 Nov 6. J Infect Chemother. 2006. PMID: 17109092
-
Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD004529. doi: 10.1002/14651858.CD004529.pub3. Cochrane Database Syst Rev. 2021. PMID: 33459345 Free PMC article.
-
[Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].Arch Pediatr. 2008 Mar;15(3):245-52. doi: 10.1016/j.arcped.2007.10.018. Epub 2008 Mar 5. Arch Pediatr. 2008. PMID: 18321692 French.
-
Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.Am J Trop Med Hyg. 1999 Apr;60(4):526-32. doi: 10.4269/ajtmh.1999.60.526. Am J Trop Med Hyg. 1999. PMID: 10348224 Clinical Trial.
-
Atovaquone and proguanil hydrochloride for treatment of malaria.J Travel Med. 1999 May;6 Suppl 1:S18-20. J Travel Med. 1999. PMID: 23573548 Review.
Cited by
-
Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis.PLoS One. 2012;7(6):e38556. doi: 10.1371/journal.pone.0038556. Epub 2012 Jun 12. PLoS One. 2012. PMID: 22701664 Free PMC article.
-
A Scoping Review of the Health of African Immigrant and Refugee Children.Int J Environ Res Public Health. 2021 Mar 28;18(7):3514. doi: 10.3390/ijerph18073514. Int J Environ Res Public Health. 2021. PMID: 33800663 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous